Market Closed -
Other stock markets
|
After market 04:35:40 pm | |||
148.5 USD | -0.69% | 147.9 | -0.45% |
02:08pm | Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study | MT |
Apr. 22 | J&J: EU green light for Carvykti in multiple myeloma | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.24% | 360B | |
+25.61% | 672B | |
+25.87% | 570B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B | |
-5.21% | 147B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson : EU to Focus on mRNA-based COVID-19 Jabs, Likely to Ditch AstraZeneca, Johnson & Johnson Shots